Posted by blueberry on December 23, 2005, at 18:33:00
In reply to Effexor metabolite submitted for FDA approval, posted by jrbecker on December 23, 2005, at 13:27:14
It's so disappointing when they come out with another antidepressant that is just another reuptake inhibitor. I mean, there are so many flaws in the reuptake monoamine theory (example only 60%ish get a 50% improvement; tianeptine, a reuptake enhancer, is equally effective in trials; on and on, etc). I wish one of these companies would think outside the box for a change. You know, those people get paid big bucks. You would think they could come up with something better than just another variation.
That being said, I am sure there will be a certain population of patients who will be helped bigtime by this new version. But still.
poster:blueberry
thread:591573
URL: http://www.dr-bob.org/babble/20051221/msgs/591679.html